Persistent’s ML algorithm accelerates LungLifeAI’s mission to transform cancer diagnosis

LungLifeAI, a pioneer in LiquidBiopsy® technology, uses machine learning and artificial intelligence to enable life-saving early diagnosis of lung cancer. Take a look at how Persistent’s ML algorithms have reduced analysis time by almost 70%, accelerating LungLife’s efforts to greatly reduce the impact of disease that claims around 400 lives per day.

Interested in learning more about Persistent’s Life Sciences Innovation and Engineering offering?

You May Be Interested In


Dattaraj Jagdish Rao talks about how AI generates convincing “fake news”, posing serious ethical issues


Sachin Kurlekar dives into the top requirements for AMR remote device management


Fernando Velez explains why organizations should implement global catalogs within their data landscapes


What you need to know before implementing artificial intelligence and machine learning – by Sameer Dixit and Jaideep Dhok


Persistent Has Embedded Sophisticated Analytics In Every Enterprise Function


Transforming user experience through emerging tech – PwC and Persistent Systems

Start typing and press Enter to search